Background: Autoimmune hepatitis (AIH) is a chronic, immune-mediated liver dysfunction. The gut microbiota and T follicular helper (Tfh) cells play critical roles in the immunopathogenesis and progression of AIH. We aimed to investigate the effect of gut microbiota combined with prednisone therapy on Tfh cell response in AIH. Methods: Samples from AIH patients and mouse model of experimental autoimmune hepatitis (EAH) were analyzed using real-time quantitative polymerase chain reaction, enzyme-linked immunosorbent assay, western blotting, flow cytometry, and hematoxylin–eosin staining to determine the role of gut microbiota on AIH. Results: Lactobacillus significantly increased the levels of Bacteroides fragilis, Clostridium, Clostridium leptum, Bifidobacterium, and Lactobacillus and significantly enhanced the suppressive effects of prednisone on the levels of AIH clinical indexes in AIH patients. Lactobacillus exerts the same prptective effects as prednisone in EAH mice and enhanced the effects of prednisone. Lactobacillus also reinforced the inhibitory effects of prednisone on the levels of serum IL-21 and the proportions of Tfh cells in peripheral blood mononuclear cells. Mechanistically, prednisone and Lactobacillus regulated Tfh cell response in EAH mice in an MyD88/NF-κB pathway-dependent manner. Conclusion: Our results suggested a therapeutic potential of Lactobacillus in the prednisone-combined treatment of AIH.
Autoimmune hepatitis (AIH) is a chronic immune-mediated inflammatory liver disease. Intestinal flora disturbance in AIH is closely related to TFH/TFR cell imbalances. As a new method of microbial therapy, the role of fecal microbiota transplantation (FMT) in AIH remains elusive. Here, we attempted to verify the functional role and molecular mechanism of FMT in AIH. An experimental autoimmune hepatitis (EAH) mouse model was established to mimic the characteristics of AIH. H&E staining was used to detect histological features in mouse liver tissues. Serological tests were employed to identify several liver function biomarkers. Flow cytometry was utilized to examine the status of TFH/TFR cell subsets. Western blotting was used to evaluate TLR pathway-associated protein abundance. RT‒qPCR was applied to evaluate Treg cell markers and inflammation marker levels in mouse liver tissues. There was significant liver inflammation and dysregulated TFR/TFH cells with elevated levels of liver inflammation-associated biomarkers in EAH mice. Interestingly, transferring therapeutic FMT into EAH mice dramatically reduced liver injury and improved the imbalance between splenic TFR and TFH cells. FMT treatment also reduced elevated contents of serum alanine transaminase (ALT), aspartate aminotransferase (AST), and total bilirubin (TBIL) in EAH mice. Furthermore, therapeutic FMT reversed the increased levels of IL-21 while promoting IL-10 and TGF-β cytokines. Mechanistically, FMT regulated TFH cell response in EAH mice in a TLR4/11/MyD88 pathway-dependent manner. Our findings demonstrated that liver injury and dysregulation between TFR and TFH cells in EAH might be reversed by therapeutic FMT via the TLR4/11-MyD88 signaling pathway.
Background: Autoimmune hepatitis (AIH) is a chronic, immune-mediated liver dysfunction. The follicular helper (TFH) T cells play critical roles in the immunopathogenesis and progression of AIH. But the underlying mechanism of the dysregulation of TFH cells in AIH remains to be determined. Therefore, we aimed to investigate the effect of gut mycobiota on TFH cell response in AIH. Methods: Samples from AIH patients and the EAH animal model were analyzed using Real-time quantitative PCR (RT-qPCR), Enzyme-linked immunosorbent assay (ELISA), western blotting, flow cytometry, and Hematoxylin-eosin (HE) staining to determine the role of gut mycobiota on autoimmune hepatitis.Results: Lactobacillus capsule could significantly increased the levels of Bacteroides fragilis, Clostridium, Clostridium leptum, Bifi, and Lacto in AIH patients and significantly decreased the levels of ALT, AST, TBIL, SMA, ANA, DAO, and ET in AIH patients. What’s more, the Lactobacillus capsule showed similar results in EAH mice. it decreased the levels of serum IL-21, the proportions of TFH cells in CD4+ T cells as well as TFH related cytokines and factors. Mechanistically, lactobacillus capsule regulated TFH response in EAH mice in DCs and MyD88/NF-κB pathway-dependent manner. Conclusion: Our results suggested a protective and therapeutic potential of probiotics in the treatment of AIH.